a drug discovery company
Orbis Medicines has raised €90M across 1 funding round from 6 investors, most recently a Series A round in Jan 2025. Based in Copenhagen, Denmark; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-01-07 | Series A | €90M |
| Cormorant,Eli Lilly,Forbion,NEA (New Enterprise Associates),Novo Holdings,The Export and Investment Fund of Denmark (EIFO) |
| View deal → |
